The Parliamentary Standing Committee of Health and Family Welfare has released its 176th report, urging the government to raise public health expenditure to 2.5% of GDP as prescribed in the National Health Policy, 2017. The report also flags the growing influence of private equity in private hospitals, and the weak implementation of the Clinical Establishments Act, 2010.
Key Developments
- Committee reiterates the need to increase public health spend from the current 1.4% of GDP to the 2.5% target of the 2017 policy.
- Supreme Court hearings continue on the applicability of Article 21 to health‑care regulation.
- Government defers responsibility to the states, citing health as a "State subject," and cites challenges in fixing a uniform rate structure for private hospitals.
- Private equity inflow is identified as a root cause of rising health‑care costs, with decisions shifting from doctors to overseas boardrooms.
- Existing schemes like PMJAY and Jan Ausadhi Yojana have limited private‑sector participation and low public awareness.
Important Facts
India’s total health‑care spend is about 3.2‑3.4% of GDP, with the private sector contributing the larger share. Land costs in Tier‑I and Tier‑II cities range from ₹50 crore to ₹250 crore for five acres, pushing hospitals toward high‑cost financing. The committee notes that without priority‑sector lending, providers resort to private equity, which raises patient bills.
Exam Relevance
Understanding the interplay between constitutional rights (Article 21), fiscal policy (health‑spend targets), and regulatory frameworks (Clinical Establishments Act) is essential for GS2 and GS3 questions. The role of Parliamentary Standing Committee illustrates parliamentary oversight mechanisms. The impact of private equity on public health costs links to economic policy and market regulation.
Way Forward
- Adopt a binding implementation mechanism for the Clinical Establishments Act across all states.
- Increase public health expenditure to the 2.5% GDP target to reduce reliance on private financing.
- Introduce priority‑sector lending for health‑care infrastructure to curb expensive private‑equity funding.
- Strengthen monitoring of schemes like PMJAY to improve awareness and private‑hospital participation.
- Establish a transparent, bulk‑buyer model for medicines and diagnostics to lower costs for patients.
Addressing these issues can move India closer to the health‑care goals set out in the National Health Policy, 2017 and ensure that the right to health under Article 21 is meaningfully realized.